Inhibition of a complement regulator in vivo enhances antibody therapy in a model of mammary adenocarcinoma.
Inhibition of a complement regulator in vivo enhances antibody therapy in a model of mammary adenocarcinoma. Int J Cancer. 2004 Jul 20; 110(6):875-81.